Case reports have raised questions about an increased risk of connecti
ve tissue diseases (CTDs) among women with breast implants, from the r
eviews of more than 2,600 manuscripts, abstracts, and dissertations, t
his meta-analysis included 13 epidemiology studies that provided a rel
ative risk (RR) estimate for the possible association between breast i
mplants and CTDs. The meta-analysis summary RR was 0.76 for CTD in gen
eral (95% confidence interval [CI]: 0.55, 1.04; homogeneity p-value =
0.073) and was 0.98 for scleroderma (95% CI: 0.57, 1.64; homogeneity p
= 0.006). Irrespective of which studies were aggregated in this meta-
analysis, there was no significant increased risk for scleroderma, rhe
umatoid arthritis, or CTD in general. Conclusions from this study are
consistent with the most recent review by the British Medical Devices
Agency that found no scientific evidence to date of an increased risk
of CTD associated with silicone gel breast implants.